Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy

This publication has 12 references indexed in Scilit:

• A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy
  AIDS, 1999
• Lipodystrophy associated with nevirapine-containing antiretroviral therapies
  AIDS, 1999
• Lipodystrophy in patients naive to HIV protease inhibitors
  AIDS, 1999
• Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy
  AIDS, 1999
• Metabolic abnormalities and body fat redistribution in HIV-1 infected patients: the lipodystrophy syndrome
  Current Opinion in Infectious Diseases, 1999
• Adverse effects of reverse transcriptase inhibitors
  AIDS, 1998
• Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
  The Lancet, 1998
• Mitochondrial dysfunction with myoclonus epilepsy and ragged-red fibers point mutation in nerve, muscle, and adipose tissue of a patient with multiple isymmetric lipomatosis
  Muscle & Nerve, 1997
• Mitochondrial DNA mutations in multiple symmetric lipomatosis
  Molecular and Cellular Biochemistry, 1997
• Mitochondrial toxicity of antiviral drugs
  Nature Medicine, 1995